Cargando…

Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology

Genetic manipulation in mice allows the discovery of gene function and biological mechanisms in vivo. The widely used Cre/LoxP system usually takes months to years especially when starting with the production of floxed alleles of a new gene of interest (GOI). Here, we describe a protocol using the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao, Xu, Bo-Lin, Chen, Xiao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220398/
https://www.ncbi.nlm.nih.gov/pubmed/34189476
http://dx.doi.org/10.1016/j.xpro.2021.100611
_version_ 1783711140693409792
author Wang, Xiao
Xu, Bo-Lin
Chen, Xiao-Wei
author_facet Wang, Xiao
Xu, Bo-Lin
Chen, Xiao-Wei
author_sort Wang, Xiao
collection PubMed
description Genetic manipulation in mice allows the discovery of gene function and biological mechanisms in vivo. The widely used Cre/LoxP system usually takes months to years especially when starting with the production of floxed alleles of a new gene of interest (GOI). Here, we describe a protocol using the CRISPR-Cas9 system to acutely inactivate the GOI in adult mice. This protocol enables hepatocyte-specific gene editing within 4 weeks in adult mice and avoids compensatory effects of traditional gene inactivation initiated during various developmental stages. For complete details on the use and execution of this protocol, please refer to Wang et al. (2020).
format Online
Article
Text
id pubmed-8220398
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82203982021-06-28 Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology Wang, Xiao Xu, Bo-Lin Chen, Xiao-Wei STAR Protoc Protocol Genetic manipulation in mice allows the discovery of gene function and biological mechanisms in vivo. The widely used Cre/LoxP system usually takes months to years especially when starting with the production of floxed alleles of a new gene of interest (GOI). Here, we describe a protocol using the CRISPR-Cas9 system to acutely inactivate the GOI in adult mice. This protocol enables hepatocyte-specific gene editing within 4 weeks in adult mice and avoids compensatory effects of traditional gene inactivation initiated during various developmental stages. For complete details on the use and execution of this protocol, please refer to Wang et al. (2020). Elsevier 2021-06-17 /pmc/articles/PMC8220398/ /pubmed/34189476 http://dx.doi.org/10.1016/j.xpro.2021.100611 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Wang, Xiao
Xu, Bo-Lin
Chen, Xiao-Wei
Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
title Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
title_full Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
title_fullStr Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
title_full_unstemmed Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
title_short Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology
title_sort acute gene inactivation in the adult mouse liver using the crispr-cas9 technology
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220398/
https://www.ncbi.nlm.nih.gov/pubmed/34189476
http://dx.doi.org/10.1016/j.xpro.2021.100611
work_keys_str_mv AT wangxiao acutegeneinactivationintheadultmouseliverusingthecrisprcas9technology
AT xubolin acutegeneinactivationintheadultmouseliverusingthecrisprcas9technology
AT chenxiaowei acutegeneinactivationintheadultmouseliverusingthecrisprcas9technology